LATS1/2 kinases trigger self-renewal of cancer stem cells in aggressive oral cancer
LATS1/2 kinases trigger self-renewal of cancer stem cells in aggressive oral cancer |
|
https://doi.org/10.18632/oncotarget.26583
Masami Nozaki,
Norikazu Yabuta,
Moe Fukuzawa,
Satomi Mukai,
Ayumi Okamoto,
Towa Sasakura,
Kohshiro Fukushima,
Yoko Naito,
Gregory D. Longmore,
and Hiroshi Nojima
|
| 1014-1030 |
Therapeutic potential of nimotuzumab PEGylated-maytansine antibody drug conjugates against EGFR positive xenograft
Therapeutic potential of nimotuzumab PEGylated-maytansine antibody drug conjugates against EGFR positive xenograft |
|
https://doi.org/10.18632/oncotarget.26613
Siddesh V. Hartimath,
Ayman El-Sayed,
Amal Makhlouf,
Wendy Bernhard,
Carolina Gonzalez,
Wayne Hill,
Angel Casaco Parada,
Kris Barreto,
Clarence Ronald Geyer,
and Humphrey Fonge
|
| 1031-1044 |
Glypican-1 and glycoprotein 2 bearing extracellular vesicles do not discern pancreatic cancer from benign pancreatic diseases
Glypican-1 and glycoprotein 2 bearing extracellular vesicles do not discern pancreatic cancer from benign pancreatic diseases |
|
https://doi.org/10.18632/oncotarget.26620
Fabrice Lucien,
Vivian Lac,
Daniel D. Billadeau,
Ayelet Borgida,
Steven Gallinger,
and Hon S. Leong
|
| 1045-1055 |
Src kinase inhibition restores E-cadherin expression in dasatinib-sensitive pancreatic cancer cells
Src kinase inhibition restores E-cadherin expression in dasatinib-sensitive pancreatic cancer cells |
|
https://doi.org/10.18632/oncotarget.26621
Austin R. Dosch,
Xizi Dai,
Alexander A. Gaidarski III,
Chanjuan Shi,
Jason A. Castellanos,
Michael N. VanSaun,
Nipun B. Merchant,
and Nagaraj S. Nagathihalli
|
| 1056-1069 |
Safety and effectiveness of FOLFOXIRI plus molecular target drug therapy for metastatic colorectal cancer: A multicenter retrospective study
Safety and effectiveness of FOLFOXIRI plus molecular target drug therapy for metastatic colorectal cancer: A multicenter retrospective study |
|
https://doi.org/10.18632/oncotarget.26626
Takatsugu Ogata,
Hironaga Satake,
Misato Ogata,
Yukimasa Hatachi,
Hayato Maruoka,
Daisuke Yamashita,
Hiroki Hashida,
Madoka Hamada,
and Hisateru Yasui
|
| 1070-1084 |
Andrographolide induces DNA damage in prostate cancer cells
Andrographolide induces DNA damage in prostate cancer cells |
|
https://doi.org/10.18632/oncotarget.26628
Ingrid S. Forestier-Román,
Andrés López-Rivas,
María M. Sánchez-Vázquez,
Krizia Rohena-Rivera,
Gretchen Nieves-Burgos,
Humberto Ortiz-Zuazaga,
Carlos A. Torres-Ramos,
and Magaly Martínez-Ferrer
|
| 1085-1101 |
Oxalate induces type II epithelial to mesenchymal transition (EMT) in inner medullary collecting duct cells (IMCD) in vitro and stimulate the expression of osteogenic and fibrotic markers in kidney medulla in vivo
Oxalate induces type II epithelial to mesenchymal transition (EMT) in inner medullary collecting duct cells (IMCD) in vitro and stimulate the expression of osteogenic and fibrotic markers in kidney medulla in vivo |
|
https://doi.org/10.18632/oncotarget.26634
Marcia Convento,
Edson Pessoa,
Alef Aragão,
Nestor Schor,
and Fernanda Borges
|
| 1102-1118 |
The correlation of p22phox and chemosensitivity in EGFR-TKI resistant lung adenocarcinoma
The correlation of p22phox and chemosensitivity in EGFR-TKI resistant lung adenocarcinoma |
|
https://doi.org/10.18632/oncotarget.26637
Masayuki Kobayashi,
Ryoko Saito,
Yasuhiro Miki,
Ren Nanamiya,
Chihiro Inoue,
Jiro Abe,
Ikuro Sato,
Yoshinori Okada,
and Hironobu Sasano
|
| 1119-1131 |
Repurposing old carbon monoxide-releasing molecules towards the anti-angiogenic therapy of triple-negative breast cancer
Repurposing old carbon monoxide-releasing molecules towards the anti-angiogenic therapy of triple-negative breast cancer |
|
https://doi.org/10.18632/oncotarget.26638
Malamati Kourti,
Andrew Westwell,
Wen Jiang,
and Jun Cai
|
| 1132-1148 |
Reliable evaluation of tumor-infiltrating lymphocytes in pancreatic cancer tissue biopsies
Reliable evaluation of tumor-infiltrating lymphocytes in pancreatic cancer tissue biopsies |
|
https://doi.org/10.18632/oncotarget.26646
Yoshinori Ino,
Seiji Oguro,
Rie Yamazaki-Itoh,
Shutaro Hori,
Kazuaki Shimada,
and Nobuyoshi Hiraoka
|
| 1149-1159 |
N-terminal pro-brain natriuretic peptide reflects both left ventricular diastolic dysfunction and myeloma-related renal insufficiency and robustly predicts mortality in patients with symptomatic multiple myeloma
N-terminal pro-brain natriuretic peptide reflects both left ventricular diastolic dysfunction and myeloma-related renal insufficiency and robustly predicts mortality in patients with symptomatic multiple myeloma |
|
https://doi.org/10.18632/oncotarget.26647
Yoshiaki Abe,
Tetsuya Kobayashi,
Yoshiaki Usui,
Kentaro Narita,
Hiroki Kobayashi,
Akihiro Kitadate,
Daisuke Miura,
Masami Takeuchi,
and Kosei Matsue
|
| 1160-1170 |
